Viewing Study NCT00911560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-09 @ 4:17 PM
Study NCT ID: NCT00911560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-05
First Post: 2009-05-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BETA-D-GLUCAN View
None OPT-821 View
None GD2-KLH View
None GD3-KLH View
None QS 21 View
None Vaccine View
None 05-075 View